Beyond Air, Inc. Increase (Decrease) in Deferred Revenue
Beyond Air, Inc. (XAIR) reported Increase (Decrease) in Deferred Revenue of -$873.00 thousand for the 12-month period ending 2021-03-31, per its 10-K filed 2022-06-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2022-06-29
- Beyond Air, Inc. increase (decrease) in deferred revenue for the quarter ending 2021-03-31 was -$145.00K, a 173.48% decline year-over-year.
- Beyond Air, Inc. increase (decrease) in deferred revenue for the quarter ending 2020-12-31 was -$149.00K.
- Beyond Air, Inc. increase (decrease) in deferred revenue for the quarter ending 2020-09-30 was -$349.84K.
- Beyond Air, Inc. increase (decrease) in deferred revenue for the quarter ending 2020-06-30 was -$229.16K.
- Beyond Air, Inc. increase (decrease) in deferred revenue for fiscal 2021 was -$873.00K.
- Beyond Air, Inc. increase (decrease) in deferred revenue for fiscal 2020 was -$1.39M, a 161.42% decline from fiscal 2019.
- Beyond Air, Inc. increase (decrease) in deferred revenue for fiscal 2019 was $2.26M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|
| 2021-03-31 | -$145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-29 | -$294.00K derived: sum of 2 quarters · filed 2022-06-29 | -$643.84K derived: sum of 3 quarters · filed 2022-06-29 | -$873.00K 10-K · filed 2022-06-29 | -$873.19K 10-K · filed 2021-06-10 | |
| 2020-12-31 | -$149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-10 | -$498.84K derived: sum of 2 quarters · filed 2022-02-10 | -$728.00K 10-Q · filed 2022-02-10 | -$530.65K derived: sum of 4 quarters · filed 2022-02-10 | ||
| 2020-09-30 | -$349.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-12 | -$579.00K 10-Q · filed 2021-11-12 | -$578.77K 10-Q · filed 2020-11-12 | -$381.65K derived: sum of 3 quarters · filed 2021-11-12 | -$696.03K derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | -$229.16K 10-Q · filed 2021-08-10 | -$31.82K derived: sum of 2 quarters · filed 2021-08-10 | -$346.19K derived: sum of 3 quarters · filed 2021-08-10 | -$991.80K derived: sum of 4 quarters · filed 2021-08-10 | ||
| 2020-03-31 | $197.35K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-10 | -$117.03K derived: sum of 2 quarters · filed 2021-06-10 | -$762.63K derived: sum of 3 quarters · filed 2021-06-10 | -$1.39M 10-K · filed 2021-06-10 | ||
| 2019-12-31 | -$314.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-07 | -$959.98K derived: sum of 2 quarters · filed 2020-11-12 | -$1.59M 10-Q · filed 2020-02-07 | |||
| 2019-09-30 | -$645.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | -$1.27M 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | -$627.47K 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | $2.26M 10-K · filed 2020-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |